Safety and immunogenicity of Modified Vaccinia Ankara (MVA-BN) smallpox vaccine in vaccinia-naïve and experienced HIV-infected individuals;
An open-label, controlled clinical Phase II trial
Overton,E.T. Stapleton, J, Frank, I, Hassler, S, Goepfert, P.F., Barker,D. et al. Open Forum Infectious Diseases May 2015 DOI: 10.1093/ofid/ofv040
Transmission Clustering Among Newly Diagnosed HIV Patients in Chicago, 2008 to 2011: Using Phylogenetics to Expand Knowledge of Regional HIV Transmission Patterns. Lubelchek RJ, Hoehnen SC, Hotton AL, Kincaid SL, Barker DE, French AL. JAIDS 2015;68(1):46-54 10.1097/ QAI.0000000000000404
Can we broaden the applicability of HIV transmission cluster analyses? Lubelchek RJ, Beavis KG, Gonzalez M, Kendrick SR, Roberts RR, Barker DE. AIDS. 2012 May 15;26(8):1043-4.
Early Development of non-Hodgkin Lymphoma Following Initiation of Newer Class Antiretroviral Therapy Among HIV-infected Patients - Implications for Immune Reconstitution Gregory D Huhn, Sheila Badri, Sonia Vibhakar, Frank Tverdek, Christopher Crank, Ronald Lubelchek, Blake Max, David Simon, Beverly Sha, Oluwatoyin Adeyemi, Patricia Herrera, Allan Tenorio, Harold Kessler and David Barker AIDS Research and Therapy Dec 14 2010, 7:44 DOI:10.1186/1742-6405-7-44
Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.–2006 William H. Wheeler, Rebecca A. Ziebell, Helena Zabina, Danuta Pieniazek, Joseph Prejean, Ulana R. Bodnar, Kristen C. Mahle, Walid Heneine, Jeffrey A. Johnson, H. Irene Hall, for the Variant, Atypical, and Resistant HIV Surveillance Group* AIDS
15 May 2010 24(8): 1203–1212
doi: 10.1097/QAD.0b013e3283388742
Comparison of 2 Doses of Liposomal Amphotericin B and Amphotericin B for the Treatment of AIDS-Associated Acute Cryptococcal Meningitis a Randomized, Double Blind Clinical Trial of Efficacy and Safety. Richard J. Hamill,1 Jack D. Sobel,2 Wafaa El-Sadr,3 Philip C. Johnson,4 John R. Graybill,5 Kedarnath Javaly,6 David E. Barker7 and the AmBisome Cryptococcal Meningitis Study Groupa Clinical Infectious Diseases 2010 Jul 15; 51(2):225-32, PMID: 20536366
Reliability at the lower limits of HIV-1 RNA quantification in clinical samples: a comparison of RT-PCR versus bDNA assays. Ronald J. Lubelchek, Blake Max, Caroline J. Sandusky, Bala Hota, David E. Barker PLoS ONE 4(6):e6008, 2009.
Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure. Sheila M. Badri, Oluwatoyin M. Adeyemi, Blake E. Max, Bala N. Hota, and David E. Barker. AIDS Patient Care and STDs August 2007, 21(8): 544-550
Cerebrospinal Fluid Abnormalities in Patients with Syphilis: Association with Clinical and Laboratory Features. Christina M. Marra, MD, Clare L. Maxwell, MD, Stacy L. Smith, BS, Sheila A. Lukehart, PhD, Anne M. Rompalo, MD, Molly Eaton, MD, Bradley P. Stoner, MD, PhD, Michael Augenbraun, MD, David E. Barker, MD, James J. Corbett, MD, Mark Zajackowski, MD, Charles Raines, CRNP, MSN, Judith Nerad, MD, Romina Kee, MD, Scott H. Barnett Jo. of Inf. Diseases 2004 Feb 1. 189:369-376
How Does Expert Advice Impact Genotypic Resistance Testing in Clinical Practice? Sheila M. Badri, Oluwatoyin M. Adeyemi, Blake E. Max, Brandon M. Zagorski, and David E. Barker. Clinical Infectious Diseases 2003
Sep 1;37(5):708-13
A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver S. AIDS 2002
Sep 6;16(13):1791-7
